Eloxx Pharmaceuticals, Inc. (ELOX)
ELOX moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How ELOX actually reacts to news — the realized, point-in-time move the market made, measured across 84 labeled events over the last three years with zero look-ahead.
ELOX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 31% | 65 |
| 30-min | 0.00% | 14% | 65 |
| 60-min | 0.00% | 23% | 66 |
| to close | 0.00% | 28% | 67 |
| Middle 50% of ELOX reactions | -2.12% to 0.00% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 84 |
Half of all Eloxx Pharmaceuticals, Inc. news events land between -2.12% and +0.00% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ELOX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ELOX's baseline. Nothing else.
Recent ELOX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form EFFECT Eloxx Pharmaceuticals, | SEC filing · Form EFFECT | SEC EDGAR | +5.12% | -0.98% | |
| Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome | Press release | PR Newswire | +0.00% | -5.91% | |
| Form S-1 Eloxx Pharmaceuticals, | SEC filing · Form S-1 | SEC EDGAR | +0.00% | +5.84% | |
| Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | PR Newswire | -0.04% | -7.85% | |
| Form 10-Q Eloxx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.04% | -7.85% | |
| Form 8-K Eloxx Pharmaceuticals, For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | -0.04% | -7.85% | |
| Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq | Press release | PR Newswire | -10.00% | +10.10% | |
| Form 8-A12B Eloxx Pharmaceuticals, | SEC filing · Form 8-A12B | SEC EDGAR | — | — | |
| Form 8-K Eloxx Pharmaceuticals, For: May 27 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form S-1/A Eloxx Pharmaceuticals, | SEC filing · Form S-1 | SEC EDGAR | — | — | |
| Form DEF 14C Eloxx Pharmaceuticals, For: May 08 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +0.00% | |
| Form S-1 Eloxx Pharmaceuticals, | SEC filing · Form S-1 | SEC EDGAR | — | — | |
| Form 10-Q Eloxx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.86% | -25.71% | |
| Form 8-K Eloxx Pharmaceuticals, For: Apr 28 | SEC filing · Form 8-K | SEC EDGAR | +3.48% | -0.77% | |
| Form PRE 14C Eloxx Pharmaceuticals, For: Apr 28 | SEC filing · Form PRE | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-K Eloxx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +0.00% | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Jun 30 | SEC filing · Form NT | SEC EDGAR | — | — | |
| Form 8-K Eloxx Pharmaceuticals, For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | +0.00% | |
| Form NT 10-K Eloxx Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | SEC EDGAR | — | — | |
| Form SEC STAFF ACTION Eloxx Pharmaceuticals, | SEC filing · Form SEC | SEC EDGAR | — | +0.00% | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Sep 30 | SEC filing · Form NT | SEC EDGAR | — | — | |
| Eloxx Pharmaceuticals Announces Key Corporate Accomplishments | Press release | GlobeNewswire | — | — | |
| Form 8-K Eloxx Pharmaceuticals, For: Oct 16 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Jun 30 | SEC filing · Form NT | SEC EDGAR | — | — | |
| Form 8-K Eloxx Pharmaceuticals, For: Jul 10 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Eloxx Pharmaceuticals Provides Pipeline and Financing Updates | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Form NT 10-Q Eloxx Pharmaceuticals, For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | +0.32% | |
| Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates | Press release | GlobeNewswire | +0.00% | -1.27% | |
| Form NT 10-K Eloxx Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | +2.04% | |
| Form 8-K Eloxx Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +2.00% | |
| Form 8-K Eloxx Pharmaceuticals, For: Mar 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.65% | |
| Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases | Press release | Business Wire | +27.55% | +3.06% | |
| Form S-3 Eloxx Pharmaceuticals, | SEC filing · Form S-3 | SEC EDGAR | -0.06% | -0.06% | |
| Form S-8 Eloxx Pharmaceuticals, | SEC filing · Form S-8 | SEC EDGAR | -0.06% | -0.06% | |
| Form 8-K Eloxx Pharmaceuticals, For: Jan 09 | SEC filing · Form 8-K | SEC EDGAR | -1.46% | -3.33% | |
| Form 8-K Eloxx Pharmaceuticals, For: Dec 27 | SEC filing · Form 8-K | SEC EDGAR | +8.70% | +4.35% | |
| Form 8-K Eloxx Pharmaceuticals, For: Dec 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update | Press release | GlobeNewswire | +0.59% | -7.79% | |
| Form 10-Q Eloxx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.59% | -7.79% | |
| Form 8-K Eloxx Pharmaceuticals, For: Nov 13 | SEC filing · Form 8-K | SEC EDGAR | +0.59% | -7.79% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ELOX section they belong to.
Where else ELOX is measured.
ELOX earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| UCB SA UNSP/ADR (UCBJY) | 85 | +0.00% | 51% |
| NUO THERAPEUTICS INC NEW (AURX) | 84 | 0.00% | 24% |
| Knight Therapeutics Inc (GUD_TSE) | 84 | 0.00% | 40% |
| Molecular Templates, Inc. (MTEM) | 84 | -0.48% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Eloxx Pharmaceuticals, Inc.'s median reaction calculated?
Every labeled ELOX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 84 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 14% of ELOX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ELOX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.